Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device

NCT04684875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-04-18

No results posted yet for this study

Summary

Evaluation of long-term (2-year) quality of life and symptoms after chronic rhinitis treatment with the Aerin InSeca/RhinAer Stylus

Conditions

  • Chronic Rhinitis

Interventions

DEVICE

Radiofrequency Stylus

Low power radiofrequency energy delivered to the posterior nasal nerve area

Sponsors & Collaborators

  • Aerin Medical

    lead INDUSTRY

Principal Investigators

  • Scott Wolf, MD · Aerin Medical, Inc.

Eligibility

Min Age
22 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-19
Primary Completion
2021-07-25
Completion
2022-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684875 on ClinicalTrials.gov